Effectiveness of peloid therapy in patients with chronic low back pain: a single-blind controlled study
rct Grade B 2021 n=106
Authors: Karaarslan, F., Yılmaz, H., Akkurt, H.E., Gül, S., Kardeş, S.
Journal: International Journal of Biometeorology 65 (11) : 1799-1809
PubMed: PMID 33931829
Key Findings
- 106 chronic low back pain patients randomized to peloid therapy plus home exercise (n=53) vs. home exercise alone (n=53)
- Peloid therapy given at 45°C for 30 minutes/day, 5 days/week for 3 weeks (15 sessions total)
- Significant improvement in pain (VAS), disability (Oswestry Disability Index), and the vitality subscale of SF-36 in the peloid group versus control
A single-blind controlled RCT comparing peloid therapy plus home exercise against home exercise alone in chronic low back pain. The peloid group showed significantly greater improvement in pain, disability, and self-reported vitality. This trial is distinct from Karaarslan 2022 (a separate RCT on mud-pack vs. hot-pack for chronic neck pain, by an overlapping author group) — it fills the back-pain evidence base with a dedicated low-back-pain peloid trial rather than relying on an adjacent condition as a proxy. Abstract-only sourcing; no full text was located.
rctchronic-low-back-painpeloid-therapysingle-blind